Moberg Pharma AB (publ) (STO: MOB)

Sweden flag Sweden · Delayed Price · Currency is SEK
18.50
+0.70 (3.93%)
Nov 20, 2024, 5:04 PM CET
128.40%
Market Cap 851.22M
Revenue (ttm) 8.78M
Net Income (ttm) -18.25M
Shares Out 46.69M
EPS (ttm) -0.55
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 358,887
Open 17.99
Previous Close 17.80
Day's Range 17.57 - 18.99
52-Week Range 8.90 - 40.90
Beta 0.95
Analysts n/a
Price Target n/a
Earnings Date Nov 12, 2024

About Moberg Pharma AB

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden. [Read more]

Sector Healthcare
Founded 2006
Employees 10
Stock Exchange Nasdaq Stockholm
Ticker Symbol MOB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.